GLIS3 and myotonic dystrophy type 2: The aim of this study was identification of probably pathogenic variants of GLIS3 in patients with MODY using a whole-exome sequencing approach and estimation of the frequency of rs806052, rs143051164, and rs149840771 in a Russian population and DM2 patients.